Beiträge

Brain Tumor Immunotherapy: What have We Learned so Far?

Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies

Dendritic cell immunotherapy in uterine cancer

Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

Myeloid-derived suppressor cells in glioma

Dendritic cell-based immunotherapy in ovarian cancer